Pharmaceutical formulation containing gelling agent

Patent Number: 9387173

Patent Date: 2016-07-12

Patent type: utility

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Inventors

First Name Last Name City State Country
Benjamin Oshlack - - -
Curtis Wright, IV - - -
Christopher D. Breder - - -

IPCs

Section Class Sub Class Group Sub Group
A 61 K 9 00
A 61 K 9 16
A 61 K 9 20
A 61 K 31 439
A 61 K 31 485
A 61 K 47 38
A 61 K 47 36
A 61 K 47 10
A 61 K 45 06
A 61 K 31 167
A 61 K 31 192
A 61 K 47 26
A 61 K 31 48
A 61 K 9 48
A 61 K 47 08
A 61 K 9 50
A 61 K 47 32
A 61 K 9 08
A 61 K 9 28
A 61 K 47 12
A 61 K 47 34
A 61 K 9 06
A 61 K 31 4458
A 61 K 31 137

Assignee

Organization First Name Last Name City State Country
Purdue Pharma L.P. - - - - -
Purdue Pharmaceuticals L.P. - - - - -
The P.F. Laboratories, Inc. - - - - -